You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Regulatory T Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Interleukins in Periodontal Disease Progression

Recruiting
  • Periodontitis
  • Gingivitis
  • Flow Cytometric Detection of Regulatory T Cells and Cytokines analysis by ELISA
  • Assiut, Asyut, Egypt
    Department of oral medicine, Periodontology, Oral diagnosis and
Nov 16, 2023

CKD (Chronic Kidney Disease) Stage 5D Trial (Sodium propionate, Placebo)

Not yet recruiting
  • CKD (Chronic Kidney Disease) Stage 5D
  • Sodium propionate
  • Placebo
  • (no location specified)
May 4, 2023

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute

Recruiting
  • Acute Rejection of Renal Transplant
  • Graft Failure
  • Donor-derived cell-free DNA
  • Loma Linda, California
    Loma Linda University Health
Jul 19, 2022

Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)

Recruiting
  • Chronic Graft vs Host Disease
  • Regulatory T-cell enriched infusion
  • Sevilla, Spain
    José Antonio Pérez Simón
May 20, 2022

Diabetes type1 Trial (cePolytreg)

Not yet recruiting
  • Diabetes type1
  • cePolytreg
  • (no location specified)
Jul 8, 2022

Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

Recruiting
  • Stem Cell Transplant Complications
  • +4 more
  • Radiation
  • +7 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

Not yet recruiting
  • Lupus Nephritis
  • Type 1 Diabetes Mellitus
  • autologous adoptive T regulatory cell transfer.
  • Cairo, Egypt
    Ain shams university, faculty of medicine
Sep 30, 2022

Healthy Volunteers Trial in Paris (ILT101, Placebo)

Completed
  • Healthy Volunteers
  • Paris, France
    Clinical Investigation Center Paris Est Hôpital Universitaire Pi
Dec 10, 2021

Thymoglobulin Versus Basiliximab on Regulatory T Cell Function

Suspended
  • KIDNEY TRANSPLANTATION
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 30, 2021

DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Minneapolis (E7777)

Recruiting
  • DLBCL
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota, Masonic Cancer Center
Jul 1, 2022

GVHD Trial in Hackensack (Cyclophosphamide and Sirolimus, Low dose IL-2 with Cytoxan + Sirolimus, Low dose IL-2, low dose

Terminated
Has Results
  • Graft Versus Host Disease
  • Cyclophosphamide and Sirolimus
  • +3 more
  • Hackensack, New Jersey
    John Theurer Cancer Center at Hackensack University Medical Cent
Feb 4, 2022

COVID19, ARDS Trial in United States (CK0802, Placebo)

Completed
  • COVID19
  • ARDS
  • CK0802
  • Placebo
  • Baltimore, Maryland
  • +4 more
Mar 8, 2022

Deficient T Regulatory Cell Function in Relapsing Remitting

Recruiting
  • Relapse Remitting Multiple Sclerosis
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Jun 13, 2022

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    Islet Transplantation Trial in Palo Alto (Infusion of recipient T regulatory cell, Infusion of concomitant Donor Derived

    Not yet recruiting
    • Islet Transplantation
    • Infusion of recipient T regulatory cell
    • Infusion of concomitant Donor Derived Vertebral Bone Marrow
    • Palo Alto, California
      Stanford University
    Jul 25, 2023

    Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

    Recruiting
    • Myeloid Leukemia, Chronic
    • +8 more
    • Conventional T cells (Tcon) and Regulatory T cells (Treg)
    • Palo Alto, California
      Stanford University School of Medicine Palo Alto, California, Un
    Aug 18, 2021

    Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

    Not yet recruiting
    • Epithelial Ovarian Cancer
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Aug 4, 2022

    Pemphigus Foliaceus, Pemphigus Vulgaris Trial in United States (Cohort 1: 1.0 x 10^8 PolyTregs, Cohort 2: 2.5x10^8 PolyTregs)

    Active, not recruiting
    Has Results
    • Pemphigus Foliaceus
    • Pemphigus Vulgaris
    • Cohort 1: 1.0 x 10^8 PolyTregs
    • Cohort 2: 2.5x10^8 PolyTregs
    • San Francisco, California
    • +3 more
    Oct 22, 2021

    Metastatic Melanoma Trial in Louisville (Ipilimumab)

    Terminated
    Has Results
    • Metastatic Melanoma
    • Louisville, Kentucky
      James Graham Brown Cancer Center
    Oct 22, 2021

    Kidney Failure, Kidney Transplant Trial in Boston (T Regulatory Cell Infusion)

    Completed
    • Kidney Failure, Kidney Transplant
    • T Regulatory Cell Infusion
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 15, 2021

    Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,

    Recruiting
    • Acute Myeloid Leukemia
    • +7 more
    • Orca-T
    • Standard-of-Care
    • Duarte, California
    • +13 more
    Jan 25, 2023

    Living Donor Kidney Transplantation Trial in Palo Alto, Chicago (Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs)

    Recruiting
    • Living Donor Kidney Transplantation
    • Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
    • Palo Alto, California
    • +1 more
    May 6, 2022

    GVHD, Allogeneic Hematopoietic Cell Transplant Recipient Trial in Palo Alto (Regulatory T Cells)

    Completed
    • Graft Versus Host Disease
    • Allogeneic Hematopoietic Cell Transplant Recipient
    • Regulatory T Cells
    • Palo Alto, California
      Stanford University, School of Medicine
    Sep 20, 2021

    GVHD Trial in Stanford (donor regulatory T lymphocytes, laboratory biomarker analysis)

    Suspended
    • Graft Versus Host Disease
    • donor regulatory T lymphocytes
    • laboratory biomarker analysis
    • Stanford, California
      Stanford University Hospitals and Clinics
    Aug 18, 2021

    Prospective Study of White Blood Cells

    Recruiting
    • Autoimmune Diseases
    • +2 more
    • White blood cell and blood collection
    • London, United Kingdom
      Quell Investigator Site 01
    Apr 6, 2021